Does FOSAPREPITANT DIMEGLUMINE Cause Off label use? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Off label use have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 6.3% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.
56
Reports of Off label use with FOSAPREPITANT DIMEGLUMINE
6.3%
of all FOSAPREPITANT DIMEGLUMINE reports
35
Deaths
44
Hospitalizations
How Dangerous Is Off label use From FOSAPREPITANT DIMEGLUMINE?
Of the 56 reports, 35 (62.5%) resulted in death, 44 (78.6%) required hospitalization, and 38 (67.9%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?
Dyspnoea (142)
Pyrexia (136)
Nausea (130)
Infusion related reaction (83)
Diarrhoea (80)
Vomiting (71)
Rash (66)
Hypersensitivity (65)
Stomatitis (64)
Decreased appetite (62)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Off label use Risk?
FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA
FOSAPREPITANT DIMEGLUMINE vs FOSCARNET
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN
FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE
FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL